Kidney Precision Medicine Project Recruitment Sites (U01 Clinical Trial Not Allowed)
Closed Posted
- Opportunity number
- RFA-DK-27-301
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $450,000
Opportunity facts
- Assistance listings
- Funding instrument
- Cooperative Agreement
- Category
-
- Health
- Eligible applicants
-
- For Profit Organizations
- Special District Governments
- Higher Education Inst. (Private)
- Independent School Districts
- Small Businesses
- 501(c)(3) Nonprofits
- Other
- Tribal Governments (Federally Recognized)
- Public or Indian Housing Auth.
- State Governments
- Tribal Organizations (Not Federally Recognized)
- City/Township Governments
- Non-501(c)(3) Nonprofits
- County Governments
- Higher Education Inst. (Public)
- Points of contact
-
- Tracy Rankin niddk_kuh@nih.gov (301) 594-6417
Opportunity details come from Grants.gov. Updated .
About this opportunity
The National Institutes of Health is soliciting applications for Kidney Precision Medicine Project Recruitment Sites under a cooperative agreement mechanism, with an application due date of July 10, 2026. This opportunity funds sites to enroll participants with acute kidney injury (AKI) and/or chronic kidney disease (CKD) into a longitudinal biopsy cohort study and perform protocol-based research kidney biopsies in collaboration with Tissue Interrogation Sites, the Kidney Tissue Atlas Coordinating Center, and the Central Hub.
Eligible applicants include for-profit organizations, nonprofits (501(c)(3) and non-501(c)(3)), higher education institutions (public and private), state and local governments, tribal governments and organizations, special district governments, independent school districts, and public or Indian housing authorities.
The program prioritizes enrollment of under-represented populations, particularly those with AKI, and emphasizes comprehensive phenotyping. New opportunities include clinical biopsies with residual tissue for research, enhanced physiologic phenotyping, repeat biopsies, pediatric recruitment, and collection of healthy reference tissue. All KPMP personnel must actively participate in scientific discovery and promote open science.
The source document (RFA-DK-27-301) was posted June 3, 2026. The opportunity is assigned to the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), administered by the National Institute of Diabetes and Digestive and Kidney Diseases. The source does not specify award amounts, number of awards, period of performance, cost share requirements, or evaluation criteria specific to this NOFO.
Synopsis
This Notice of Funding Opportunity (NOFO) requests applications for Kidney Precision Medicine Project (KPMP) Recruitment Sites (RS) to enroll people with Acute Kidney Injuries (AKI) and/or Chronic Kidney Diseases (CKD) into a longitudinal biopsy cohort study. Under-enrolled populations (e.g., AKI) and comprehensive phenotyping remain priorities. New opportunities include clinical biopsies with residual tissue for research, enhanced physiologic phenotyping, repeat biopsies, pediatric recruitment, and collection of healthy reference tissue. All KPMP personnel will actively participate in scientific discovery and promote open science.
Files
| File | Type | Posted |
|---|---|---|
| RFA-DK-27-301-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity